Chapter VII
Transition of pemphigus vulgaris into pemphigus foliaceus confirmed by antidesmoglein ELISA profile Summary We describe a case of transition from pemphigus vulgaris into pemphigus foliaceus accompanied by distinct shift in anti-desmoglein antibody profile as detected by ELISA.
The patient presented with painful oral erosions, later followed by flaccid blisters and erosions on the skin. A diagnosis of pemphigus vulgaris was made based on the typical clinical presentation and histopathology, immunofluorescence, and ELISA studies.
Successful therapy consisted of daily prednisolone up to 60 mg, adjuvant dexamethasone pulse therapy and azathioprine. After a period of eight months in complete remission the patient presented again with a new solitary erythematous lesion on the scalp with crusted scales. Histology showed clefting of the granular layer with acantholysis. Apparently the pemphigus vulgaris had transformed into pemphigus foliaceus. This shift from PV to PF was accompanied by the disappearance of anti-desmoglein 3 (dsg3) antibodies and the reoccurrence of anti-desmoglein 1 (dsg1) antibodies as detected by ELISA.
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Introduction
The main subtypes of pemphigus, vulgaris (PV) and foliaceus (PF), are characterized by distinct clinical, histological, and autoantibody features. Pemphigus autoantibodies are directed against the extracellular domains of the desmosomal adhesion molecules desmoglein 1 and 3 (1;2).
Transformation between the subtypes PV and PF is rarely reported in the literature.
Nevertheless if such transformation does occur, then a shift from PV to PF is more common (3-9) than, vice versa, a shift from PF to PV (6;9;10). Until recently only western blot was available for determining serum antibody specificity but unfortunately immunoblotting is not very reliable in pemphigus. Due to the conformational character of part of the desmoglein epitopes many sera may give false-negative results for either desmoglein 1 or 3 or both. Recently, a transformation from PF to PV was confirmed by the desmoglein autoantibody profile as detected by ELISA (10) . We present a case in which the shift from PV into PF was accompanied by disappearance of anti-desmoglein 3 and autonomous reappearance of anti-desmoglein 1, demonstrated by longitudinal follow-up.
Case report
In 1997, a 28-year-old Turkish man was referred to us with since 7 months painful lesions in the mouth, later followed by flaccid blisters and erosions on scalp, slowly on the scalp consisting of erythema with crusted scales. Histology showed clefting of the granular layer, with acantholysis ( Fig IB) . ELISA for circulating anti-desmoglein 1 IgG gave a positive index-value of 77, whereas anti-dsg 3 was negative ( Fig II) . Indirect IF remained low at titre 1:20 for anti-ICS IgG. The pemphigus vulgaris had transformed into pemphigus foliaceus. Topical clobetasol dipropionate cream was applied in addittion to low-dose prednisolone without success. The patient did not suffer from the lesion on the scalp, and there was no disease progression. Treatment was not necessary. 
Discussion
Onset, progress, and transition of pemphigus depends on genetic, and exogenous factors.
The development of antidesmoglein 1 antibodies in addition to antidesmoglein 3 antibodies in pemphigus vulgaris is not uncommon and correlates with disease progression from mucous membranes to skin (11) . However, switching off antidesmoglein 3 antibodies in the presence of antidesmoglein 1 antibodies is uncommon and results in transition of PV into PF (2) . The reason for the persistence of antidesmoglein 3 antibodies during the course of PV is unclear.
The disease period before transition may vary between 1-20 years (3) . The shift from PV to PF has been reported before, in studies using immunoblot in which a shift from 130-kDa PV antigen (dsg3) to 160 kDa PF antigen (dsg1) was shown (3-5;7) .
Immunoblotting however, is not quantitative and often false-negative, and therefore the relation between disease activity and anti-dsg IgG titre cannot be assessed. ELISA using the ectodomains of respectively dsg1 and dsg 3 as substrates specifically measures in a quantitative way circulating autoantibodies against desmoglein 1 and 3. IgG for determining the initial therapy for PF (13) . PF patients with low ELISA titre may be treated with topical steroids, whereas those with high titres with glucocorticoid pulse therapy.
Our patient developed PF with crusted scales on the scalp two years after the initial diagnosis of PV. The positive anti-dsg 1 and negative anti-dsg 3 ELISA titres, supported by the acantholysis in the upper epidermis confirmed the clinical shift into PF. Indirect IF titre remained at 1:20. In this case the ELISA values signaled us the shift in autoantibody response, and lead to a quick diagnosis, and also our choice for a milder treatment modality, since the course of PF (although sometimes chronic and refractory) is milder than in PV. Besides, this case demonstrated desmoglein 1 and 3 to change autonomously, demonstrated by the ELISA titres during a follow-up of 55 months.
